333
Views
18
CrossRef citations to date
0
Altmetric
Gastrointestinal Cancer

Comparison of guaiac and immunological fecal occult blood tests in colorectal cancer screening: The patient perspective

, , , , , , & show all
Pages 1345-1349 | Received 21 Apr 2010, Accepted 27 May 2010, Published online: 21 Jun 2010

References

  • Towler BP, Irwig L, Glasziou P, Weller D, Kewenter J. Screening for colorectal cancer using the faecal occult blood test, hemoccult. Cochrane Database Syst Rev 2000;2:CD001216.
  • Benson VS, Patnick J, Davies AK, Nadel MR, Smith RA, Atkin WS. Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. Int J Cancer 2008;122(6):1357–67.
  • van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008;1:82–90.
  • Hol L, Wilschut JA, van Ballegooijen M, van Vuuren AJ, van der Valk H, Reijerink JC, Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br J Cancer 2009;100(7):1103–10.
  • Dutch Health Council (Gezondheidsraad). Wet bevolkingsonderzoek: proefbevolkingsonderzoek naar darmkanker Publication number2005/03wbo. The Hague: the Netherlands; 2005.
  • Deutekom M, van Rijn AF, Dekker E, Blaauwgeers H, Stronks K, Fockens P, Uptake of faecal occult blood test colorectal cancer screening by different ethnic groups in the Netherlands. Eur J Public Health 2009;19(4):400–2.
  • van Rijn AF, van Rossum LG, Deutekom M, Laheij RJ, Fockens P, Bossuyt PM, Low priority main reason not to participate in a colorectal cancer screening program with a faecal occult blood test. J Public Health (Oxf) 2008;30(4):461–5.
  • van Rossum LGM, van Rijn AF, Laheij RJF, van Oijen MGH, Fockens P, Jansen JBMJ, Cutoff value determines the performance of a semi-quantitative immunochemical faecal occult blood test in a colorectal cancer screening programme. Br J Cancer 2009;101:1274–81.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.